| RS186694298 |
LMF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Lipase deficiency |
| RS186695833 |
RHOBTB2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS186699341 |
TBCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Inborn genetic diseases |
| RS186699871 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myopathy |
| RS186703073 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex, Ogna type |
| RS1867034667 |
MTMR2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS186704689 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS186705952 |
PEX7
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhizomelic chondrodysplasia punctata type 1, Peroxisome biogenesis disorder 9B |
| RS186709388 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS186710233 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Inborn genetic diseases |
| RS186712522 |
RIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
RIN2-related disorder, RIN2-related disorder |
| RS186713451 |
BBS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome |
| RS186717040 |
ATP6V0A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal renal tubular acidosis, Renal tubular acidosis |
| RS186717113 |
REN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesis |
| RS186717319 |
TUSC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, Intellectual disability |
| RS186736134 |
EHHADH
|
Health Risk |
Conflicting classifications of pathogenicity |
EHHADH-related disorder, EHHADH-related disorder |
| RS186736979 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bilateral frontoparietal polymicrogyria, Bilateral frontoparietal polymicrogyria |
| RS186739900 |
AICDA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgM syndrome type 2, Hyper-IgM syndrome type 2 |
| RS186741807 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Congestive heart failure, Long QT syndrome |
| RS186745328 |
WWOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS186746130 |
FGFR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Craniosynostosis syndrome, Pfeiffer syndrome |
| RS186746372 |
PTPRQ
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS186756601 |
PCCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS1867604292 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS186763441 |
FMO3
|
Health Risk |
Conflicting classifications of pathogenicity |
Trimethylaminuria, FMO3-related disorder |
| RS186768244 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS186771094 |
LAMB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pierson syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS186774726 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS186775751 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS186780639 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21 |
| RS186788522 |
DST
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS186794216 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS186809500 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS186810296 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, OTOF-related disorder |
| RS186812006 |
FCHO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS186812403 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS186814909 |
NPR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS186818985 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS186820592 |
RBBP8
|
Health Risk |
Conflicting classifications of pathogenicity |
Jawad syndrome, Seckel syndrome 2 |
| RS186822052 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS186823009 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS186823399 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS186828918 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal-hepatic-pancreatic dysplasia 1, NPHP3-related Meckel-like syndrome |
| RS186829587 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS186829827 |
PLCG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 3, Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation |
| RS186834921 |
LONP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS186836845 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Ullrich congenital muscular dystrophy 2 |
| RS186838169 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS186838828 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Channelopathy-associated congenital insensitivity to pain, autosomal recessive |
| RS186839881 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1868403104 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1868408180 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1868424934 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS186842823 |
KCNJ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial fibrillation, familial |
| RS186842903 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Woolly hair-skin fragility syndrome, Arrhythmogenic right ventricular dysplasia 8 |
| RS1868480299 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1868481514 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS186851083 |
NEBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Familial cancer of breast |
| RS1868517084 |
IFT81
|
Health Risk |
Pathogenic/Likely pathogenic |
Short-rib thoracic dysplasia 19 with or without polydactyly, Short-rib thoracic dysplasia 19 with or without polydactyly |
| RS1868532995 |
LEMD3
|
Health Risk |
Pathogenic |
— |
| RS1868561938 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1868567420 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS186857044 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1868578034 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS186859429 |
GNAL
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonic disorder, Inborn genetic diseases |
| RS186859701 |
NPRL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial focal |
| RS1868615639 |
SACS
|
Health Risk |
Pathogenic |
— |
| RS1868618470 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1868624031 |
TBX3
|
Health Risk |
Likely pathogenic |
— |
| RS1868626730 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1868628768 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS186864136 |
LPIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Majeed syndrome, Autoinflammatory syndrome |
| RS1868641702 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS186864205 |
TP63
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofacial cleft 8, Ectrodactyly |
| RS186864272 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Susceptibility to mononeuropathy of the median nerve |
| RS186864802 |
MMAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic aciduria, cblB type |
| RS186865544 |
DIS3L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Perlman syndrome, DIS3L2-related disorder |
| RS186866326 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Usher syndrome type 1 |
| RS186867242 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1868687508 |
MIP
|
Health Risk |
Likely pathogenic |
Cataract 15 multiple types, Cataract 15 multiple types |
| RS1868700605 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1868706209 |
TBX3
|
Health Risk |
Likely pathogenic |
Ulnar-mammary syndrome, Ulnar-mammary syndrome |
| RS1868755540 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS186878627 |
SLC5A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 1, Thyroid dyshormonogenesis 1 |
| RS186881889 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS186882443 |
HTT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS186882839 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS186883352 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Floating-Harbor syndrome, Developmental delay |
| RS1868854677 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1868862742 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1868872666 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1868886361 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1868888758 |
TBX5
|
Health Risk |
Pathogenic |
— |
| RS1868900449 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1868908326 |
TBX3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1868915593 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1868917066 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS186892978 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyropoikilocytosis, hereditary |
| RS1868929983 |
SACS
|
Health Risk |
Pathogenic |
— |
| RS186893286 |
BBS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |